Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Sponsors and Collaborators
Allergan

Contact
Allergan Inc.
clinicaltrials@allergan.com

ClinicalTrials.gov Identifier
NCT00439140